NCT06493526View on ClinicalTrials.gov

Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Kidney Transplantation
Interventions
DRUG

Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids.

Mycophenolate mofetil dose will be optimized to an AUC12 of 60 h.mg/L, thereafter the calcineurin inhibitor will be withdrawn.

Trial Locations (1)

2650

RECRUITING

University Hospital Antwerp, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER